Jared Haase
Stock Analyst at William Blair
(4.35)
# 1,302
Out of 4,673 analysts
61
Total ratings
86.8%
Success rate
21.1%
Average return
Main Sectors:
Stocks Rated by Jared Haase
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADUS Addus HomeCare | Reiterated: Buy | n/a | $120.81 | - | 5 | Aug 19, 2026 | |
| USPH U.S. Physical Therapy | Reiterated: Hold | n/a | $78.21 | - | 7 | Aug 14, 2026 | |
| DNA Ginkgo Bioworks Holdings | Maintained: Sell | n/a | $7.40 | - | 2 | Aug 13, 2026 | |
| AVAH Aveanna Healthcare Holdings | Reiterated: Buy | n/a | $13.16 | - | 8 | Aug 13, 2026 | |
| LFCR Lifecore Biomedical | Reiterated: Buy | n/a | $4.54 | - | 2 | Aug 11, 2026 | |
| CON Concentra Group Holdings Parent | Reiterated: Buy | n/a | $35.00 | - | 2 | Aug 6, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | n/a | $295.19 | - | 1 | Aug 5, 2026 | |
| EHC Encompass Health | Reiterated: Buy | n/a | $120.31 | - | 8 | Aug 5, 2026 | |
| PNTG The Pennant Group | Reiterated: Buy | n/a | $38.88 | - | 5 | Aug 5, 2026 | |
| CERT Certara | Maintained: Hold | n/a | $8.43 | - | 1 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $58.87 | - | 6 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $336.34 | - | 1 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $172.23 | - | 1 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $18.39 | - | 2 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $259.82 | - | 1 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $244.39 | - | 1 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $620.75 | - | 1 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7141 | - | 3 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.96 | - | 4 | May 5, 2026 |
Addus HomeCare
Aug 19, 2026
Reiterated: Buy
Price Target: n/a
Current: $120.81
Upside: -
U.S. Physical Therapy
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $78.21
Upside: -
Ginkgo Bioworks Holdings
Aug 13, 2026
Maintained: Sell
Price Target: n/a
Current: $7.40
Upside: -
Aveanna Healthcare Holdings
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.16
Upside: -
Lifecore Biomedical
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.54
Upside: -
Concentra Group Holdings Parent
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.00
Upside: -
Charles River Laboratories International
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $295.19
Upside: -
Encompass Health
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $120.31
Upside: -
The Pennant Group
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $38.88
Upside: -
Certara
Aug 5, 2026
Maintained: Hold
Price Target: n/a
Current: $8.43
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $58.87
Upside: -
Jul 30, 2026
Maintained: Buy
Price Target: n/a
Current: $336.34
Upside: -
Jul 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $172.23
Upside: -
Jul 29, 2026
Maintained: Hold
Price Target: n/a
Current: $18.39
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $259.82
Upside: -
Jul 23, 2026
Maintained: Buy
Price Target: n/a
Current: $244.39
Upside: -
Jul 23, 2026
Reiterated: Hold
Price Target: n/a
Current: $620.75
Upside: -
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $0.7141
Upside: -
May 5, 2026
Maintained: Hold
Price Target: n/a
Current: $10.96
Upside: -